Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

IMPORTANCE: Tafamidis has been shown to improve survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with placebo. However, its effect on cardiac function has not been fully characterized. OBJECTIVE: To examine the effect of tafamidis on cardiac function in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sanjiv J., Fine, Nowell, Garcia-Pavia, Pablo, Klein, Allan L., Fernandes, Fabio, Weissman, Neil J., Maurer, Mathew S., Boman, Kurt, Gundapaneni, Balarama, Sultan, Marla B., Elliott, Perry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652219/
https://www.ncbi.nlm.nih.gov/pubmed/37966817
http://dx.doi.org/10.1001/jamacardio.2023.4147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652219/
https://www.ncbi.nlm.nih.gov/pubmed/37966817
http://dx.doi.org/10.1001/jamacardio.2023.4147

Ejemplares similares